Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 29, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,249	4,103	5,341	8,945	7,761	4,350
Market Cap Growth	-23.18%	-23.18%	-40.29%	15.26%	78.41%	80.42%
Enterprise Value	4,038	3,795	3,388	6,198	6,696	3,786
Last Close Price	19.36	18.40	22.79	35.27	29.00	16.92
PE Ratio	106.95	55.06	71.28	2.13	5.49	9.28
PS Ratio	11.83	11.72	7.13	0.85	2.74	4.54
PB Ratio	0.71	0.67	0.85	1.32	2.72	3.90
P/TBV Ratio	0.73	0.70	0.89	1.38	2.80	4.01
P/FCF Ratio	-	-	18.91	2.42	7.58	13.13
P/OCF Ratio	-	-	13.61	2.23	6.89	12.09
EV/Sales Ratio	11.25	10.84	4.52	0.59	2.37	3.95
EV/EBITDA Ratio	-	89.55	57.13	1.20	3.93	6.74
EV/EBIT Ratio	-	-	-	1.21	3.98	6.95
EV/FCF Ratio	-12.27	-	11.99	1.68	6.54	11.43
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.02	0.13
Debt / EBITDA Ratio	0.58	0.58	0.64	0.04	0.03	0.25
Debt / FCF Ratio	-	-	0.17	0.06	0.04	0.43
Asset Turnover	-	-	0.09	1.67	1.17	0.93
Inventory Turnover	-	-	1.60	14.70	3.52	2.68
Quick Ratio	-	-	2.42	3.10	4.84	3.42
Current Ratio	-	-	2.70	3.25	5.50	3.94
Return on Equity (ROE)	0.43%	0.43%	1.06%	91.05%	72.97%	54.97%
Return on Assets (ROA)	-	-	-0.05%	50.90%	43.43%	32.96%
Return on Capital (ROIC)	-0.15%	-0.15%	-0.07%	65.03%	50.68%	36.36%
Return on Capital Employed (ROCE)	-	-	-	75.20%	58.60%	48.70%
Earnings Yield	0.91%	1.82%	1.40%	47.05%	18.21%	10.78%
FCF Yield	-7.74%	-6.58%	5.29%	41.36%	13.19%	7.62%
Dividend Yield	6.35%	-	0.53%	9.90%	6.99%	3.80%
Payout Ratio	121.84%	63.59%	777.41%	13.08%	20.05%	1.80%
Buyback Yield / Dilution	0.54%	0.54%	1.22%	-8.61%	-1.43%	-0.23%
Total Shareholder Return	1.17%	0.54%	1.75%	1.29%	5.56%	3.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.